J. Vandooren
Cancer Research · 2013
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 28 citations into it
- Oncology — 19 citations into it
- Molecular Biology — 18 citations into it
- Hematology — 8 citations into it
Whom J. Vandooren trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- P. E. Van den Steen
- W. Parks
- G. Opdenakker
- Christopher M. Overall
- N. Borregaard
- D. Moazed
- D. Hanahan
- M. Inoue
- T. Klein
Who trusts J. Vandooren overall
Papers from J. Vandooren's perspective
Ordered by how strongly the researchers J. Vandooren trusts endorse each paper. Same corpus, a different order for every researcher.
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations (Science)
- Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. (Genes & Development)
- Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. (Blood)
- Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. (Cell)
- Matrix metalloproteinases as modulators of inflammation and innate immunity (Nature reviews. Immunology)
- Structure and function of matrix metalloproteinases and TIMPs. (Cardiovascular Research)
- Metalloproteinase inhibitors: biological actions and therapeutic opportunities (Journal of Cell Science)
- Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
- Gelatinase B functions as regulator and effector in leukocyte biology (Journal of Leukocyte Biology)